News & Views | Published:

New modifier loci in cystic fibrosis

Nature Genetics volume 43, pages 508509 (2011) | Download Citation

A genome-wide association study has identified two new loci modifying pulmonary disease severity in cystic fibrosis. Although this data offers clues to pathways influencing pulmonary function, the underlying genes and mechanisms remain to be elucidated.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Science 245, 1066–1073 (1989).

  2. 2.

    et al. Science 245, 1073–1080 (1989).

  3. 3.

    et al. Nat. Genet. 43, 539–546 (2011).

  4. 4.

    Annu. Rev. Physiol. 55, 609–630 (1993).

  5. 5.

    Cystic Fibrosis Genotype-Phenotype Consortium. N. Engl. J. Med. 329, 1308–1313 (1993).

  6. 6.

    et al. Pediatrics 93, 114–118 (1994).

  7. 7.

    et al. Pediatr. Pulmonol. 31, 1–12 (2001).

  8. 8.

    Ann. NY Acad. Sci. 1214, 57–69 (2010).

  9. 9.

    et al. J. Clin. Invest. 104, 431–437 (1999).

  10. 10.

    et al. Br. Med. J. 319, 1166–1167 (1999).

  11. 11.

    et al. Immunogenetics 40, 37–44 (1994).

  12. 12.

    et al. N. Engl. J. Med. 353, 1443–1453 (2005).

  13. 13.

    et al. Nature 458, 1039–1042 (2009).

Download references

Author information

Affiliations

  1. Heiko Witt is at Else Kröner-Fresenius-Zentrum for Nutritional Medicine and the Department of Paediatrics, Technische Universität München (TUM), Munich, Germany.

    • Heiko Witt

Authors

  1. Search for Heiko Witt in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Heiko Witt.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ng.844

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing